The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

Chimeric antigen receptors (CARs) are effective tools for directing T cell killing of tumors, but may cause adverse side effects. Here the authors show that coupling of antigen-recognition and CD3-binding in a modular format induces more efficient anti-tumour responses but reduced toxicity when comp...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher W. Helsen, Joanne A. Hammill, Vivian W. C. Lau, Kenneth A. Mwawasi, Arya Afsahi, Ksenia Bezverbnaya, Lisa Newhook, Danielle L. Hayes, Craig Aarts, Bojana Bojovic, Galina F. Denisova, Jacek M. Kwiecien, Ian Brain, Heather Derocher, Katy Milne, Brad H. Nelson, Jonathan L. Bramson
Format: article
Language:EN
Published: Nature Portfolio 2018
Subjects:
Science
Q
Online Access:https://doaj.org/article/e6ef202d9e6344acbce6ee90ed3c483d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/e6ef202d9e6344acbce6ee90ed3c483d

Similar Items